US OptionsDetailed Quotes
ATRC241220C30000
- 0.00
- 0.000.00%
15min DelayClose Dec 13 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest30.00Strike Price0.00Turnover104.05%IV-5.27%PremiumDec 20, 2024Expiry Date1.67Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.6966Delta0.0916Gamma12.80Leverage Ratio-0.1446Theta0.0026Rho8.91Eff Leverage0.0128Vega
AtriCure Stock Discussion
Sign in to post a comment
$Garmin (GRMN.US)$ $AtriCure (ATRC.US)$ $Vast Renewables (VSTE.US)$ $ASP Isotopes (ASPI.US)$ $Unisys (UIS.US)$ $Solidion Technology (STI.US)$ $NerdWallet (NRDS.US)$ $Xilio Therapeutics (XLO.US)$ $Cryo-Cell International (CCEL.US)$ $Omnicell (OMCL.US)$ $Reddit (RDDT.US)$ $Ensysce Biosciences (ENSC.US)$ $Tharimmune (THAR.US)$
5
1
1
$SeaStar Medical (ICU.US)$ $Direxion Daily GOOGL Bull 2X Shares (GGLL.US)$ $Torrid (CURV.US)$ $Snap Inc (SNAP.US)$ $60 Degrees Pharmaceuticals (SXTP.US)$ $GlycoMimetics (GLYC.US)$ $Mirion (MIR.US)$ $AtriCure (ATRC.US)$ $Reddit (RDDT.US)$ $Magic Empire Global (MEGL.US)$ $Sky Quarry (SKYQ.US)$ $Enovix (ENVX.US)$ $NerdWallet (NRDS.US)$ $Starbox Group (STBX.US)$
📊⚡️📊
📊⚡️📊
3
Insider transactions at AtriCure are not encouraging. However, insiders' share ownership suggests some alignment. Maggie Yuen's sale at a price above the current share price may not reflect insider confidence.
Investors forecast sustained strong revenue performance from AtriCure, reflected in a high P/S ratio. Shareholders currently show confidence in the company's future revenue, bolstering its shares. The high P/S ratio is deemed appropriate due to robust future revenues.
The lack of insider purchasing and ample selling in the past year could be red flags for potential investors in AtriCure. Despite high insider ownership, absence of buying is unsettling. Additionally, unspecified risks and concerns for AtriCure are noteworthy.
No comment yet
Den the Dragon :
